BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26613645)

  • 1. Dynorphin inhibits basal forebrain cholinergic neurons by pre- and postsynaptic mechanisms.
    Ferrari LL; Agostinelli LJ; Krashes MJ; Lowell BB; Scammell TE; Arrigoni E
    J Physiol; 2016 Feb; 594(4):1069-85. PubMed ID: 26613645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine inhibits basal forebrain cholinergic and noncholinergic neurons in vitro.
    Arrigoni E; Chamberlin NL; Saper CB; McCarley RW
    Neuroscience; 2006 Jun; 140(2):403-13. PubMed ID: 16542780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the basal forebrain by the orexin/hypocretin neurones.
    Arrigoni E; Mochizuki T; Scammell TE
    Acta Physiol (Oxf); 2010 Mar; 198(3):223-35. PubMed ID: 19723027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Lateral Hypothalamic Orexin Activity by Local GABAergic Neurons.
    Ferrari LL; Park D; Zhu L; Palmer MR; Broadhurst RY; Arrigoni E
    J Neurosci; 2018 Feb; 38(6):1588-1599. PubMed ID: 29311142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vesicular glutamate (VGlut), GABA (VGAT), and acetylcholine (VACht) transporters in basal forebrain axon terminals innervating the lateral hypothalamus.
    Henny P; Jones BE
    J Comp Neurol; 2006 Jun; 496(4):453-67. PubMed ID: 16572456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Descending projections from the basal forebrain to the orexin neurons in mice.
    Agostinelli LJ; Ferrari LL; Mahoney CE; Mochizuki T; Lowell BB; Arrigoni E; Scammell TE
    J Comp Neurol; 2017 May; 525(7):1668-1684. PubMed ID: 27997037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential target-dependent actions of coexpressed inhibitory dynorphin and excitatory hypocretin/orexin neuropeptides.
    Li Y; van den Pol AN
    J Neurosci; 2006 Dec; 26(50):13037-47. PubMed ID: 17167093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orexin peptides enhance median preoptic nucleus neuronal excitability via postsynaptic membrane depolarization and enhancement of glutamatergic afferents.
    Kolaj M; Coderre E; Renaud LP
    Neuroscience; 2008 Sep; 155(4):1212-20. PubMed ID: 18674591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innervation of orexin/hypocretin neurons by GABAergic, glutamatergic or cholinergic basal forebrain terminals evidenced by immunostaining for presynaptic vesicular transporter and postsynaptic scaffolding proteins.
    Henny P; Jones BE
    J Comp Neurol; 2006 Dec; 499(4):645-61. PubMed ID: 17029265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state.
    Strecker RE; Morairty S; Thakkar MM; Porkka-Heiskanen T; Basheer R; Dauphin LJ; Rainnie DG; Portas CM; Greene RW; McCarley RW
    Behav Brain Res; 2000 Nov; 115(2):183-204. PubMed ID: 11000420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orexins/hypocretins excite basal forebrain cholinergic neurones.
    Eggermann E; Serafin M; Bayer L; Machard D; Saint-Mleux B; Jones BE; Mühlethaler M
    Neuroscience; 2001; 108(2):177-81. PubMed ID: 11734353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action.
    España RA; Baldo BA; Kelley AE; Berridge CW
    Neuroscience; 2001; 106(4):699-715. PubMed ID: 11682157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal forebrain cholinergic modulation of sleep transitions.
    Irmak SO; de Lecea L
    Sleep; 2014 Dec; 37(12):1941-51. PubMed ID: 25325504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system.
    Fu LY; Acuna-Goycolea C; van den Pol AN
    J Neurosci; 2004 Oct; 24(40):8741-51. PubMed ID: 15470140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organization of hypocretin/orexin efferents to locus coeruleus and basal forebrain arousal-related structures.
    España RA; Reis KM; Valentino RJ; Berridge CW
    J Comp Neurol; 2005 Jan; 481(2):160-78. PubMed ID: 15562511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal Forebrain Cholinergic Neurons Have Specific Characteristics during the Perinatal Period.
    Lozovaya N; Moumen A; Hammond C
    eNeuro; 2024 May; 11(5):. PubMed ID: 38755010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine inhibits activity of hypocretin/orexin neurons by the A1 receptor in the lateral hypothalamus: a possible sleep-promoting effect.
    Liu ZW; Gao XB
    J Neurophysiol; 2007 Jan; 97(1):837-48. PubMed ID: 17093123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypocretin/orexin antagonism enhances sleep-related adenosine and GABA neurotransmission in rat basal forebrain.
    Vazquez-DeRose J; Schwartz MD; Nguyen AT; Warrier DR; Gulati S; Mathew TK; Neylan TC; Kilduff TS
    Brain Struct Funct; 2016 Mar; 221(2):923-40. PubMed ID: 25431268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycinergic Input to the Mouse Basal Forebrain Cholinergic Neurons.
    Bardóczi Z; Pál B; Kőszeghy Á; Wilheim T; Watanabe M; Záborszky L; Liposits Z; Kalló I
    J Neurosci; 2017 Sep; 37(39):9534-9549. PubMed ID: 28874448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine inhibits glutamatergic input to basal forebrain cholinergic neurons.
    Hawryluk JM; Ferrari LL; Keating SA; Arrigoni E
    J Neurophysiol; 2012 May; 107(10):2769-81. PubMed ID: 22357797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.